-
Pharma Firms Looking Toward Biotech Industry – (PFE, FRX, BMY, LLY, EXEL, ARNA, AMGN, GILD)
The pharmaceutical industry is standing in the middle of one of the largest patent cliffs with Pfizer Inc. (NYSE:PFE)’s multi-billion-dollar epic drug Lipitor losing patent protection in the US in late November 2011. Other than Lipitor, key branded drugs that lost patent protection in the last couple of months include Lexapro by Forest Laboratories, Inc.…
-
Biotech Merger & Acquisition Volume Hits The Biggest Since 2008 – (ARNA, GILD, INCY)
Biotech merger volume across the world has hit levels not seen in four years as large pharmaceutical companies chase contracts to get access to new drugs, with bankers saying therapeutic areas including cancer, inflammation and autoimmune diseases are emerging as highly attractive. Healthcare bankers at Credit Suisse Group (NYSE:CS) said those pharmaceutical giants with expired…
-
Biotech Stocks Manage To Resist The Broad Market Weakness And Rough Trading Acitivty – (ARNA, DNDN, ZLCS)
Despite a change in the broad market which appeared during March of current year, companies in the biotechnology industry have managed to resist the general market weakness and generally rough trading environment that caused confusion among investors. Many believe bio-tech is a part of contrarian strength in a weak economic situation because the cure for…
-
Peregrine Pharmaceuticals (NASDAQ:PPHM) Leads Top Gainers For July In The Biotechnology Industry – (AMGN, BDSI, SRPT, SQNM, GILD, ARNA)
Shares in the biotechnology industry, which features companies such as Amgen, Inc. (NASDAQ:AMGN) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI), were mixed on Monday with Peregrine Pharmaceuticals (NASDAQ:PPHM) and Sarepta Therapeutics Inc(NASDAQ:SRPT) leading gains for July. Omeros Corporation (NASDAQ:OMER) recently announced that it has discovered the proteins that activate the alternative pathway of the complement system,…
-
Top Gainers For 2012 Among Biotech Stocks – (SPPI, ARNA, GILD, CELG, BDSI, THLD, SRPT, DNDN)
Biotechnology industry, which features companies such as Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG), is turning out to be a favorite among investors trying to raise their alternatives. The indsutry gains so far this year are led by BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Threshold Pharmaceuticals, Inc. (NASDAQ:THLD). Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares…